The link between high blood concentrations of omega-3 fatty acids and an increased risk of prostate cancer has been confirmed in a new prospective study.
The findings, published in the Journal of the National Cancer Institute indicate that high concentrations of EPA, DPA and DHA – the three anti-inflammatory and metabolically related fatty acids derived from fatty fish and fish-oil supplements – are associated with a 71% increased risk of high-grade prostate cancer.
Read more at Journal of the National Cancer Institute